These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 14974908

  • 21. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [Abstract] [Full Text] [Related]

  • 22. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 23. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
    Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM.
    Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
    [Abstract] [Full Text] [Related]

  • 24. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 25. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
    Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC, WHISP (Women's Hormone Intervention Secondary Prevention Study) Pilot Study Investigators.
    Eur Heart J; 2006 Sep; 27(17):2046-53. PubMed ID: 16899475
    [Abstract] [Full Text] [Related]

  • 26. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
    Kwok S, Charlton-Menys V, Pemberton P, McElduff P, Durrington PN.
    Maturitas; 2006 Mar 20; 53(4):439-46. PubMed ID: 16139447
    [Abstract] [Full Text] [Related]

  • 27. [Cardiovascular risk and hormone replacement therapy in menopause].
    Plu-Bureau G.
    Therapie; 1999 Mar 20; 54(3):375-80. PubMed ID: 10500454
    [Abstract] [Full Text] [Related]

  • 28. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 20; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 29. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 20; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 30. [Menopause and hormone replacement therapy (HRT) in women with diabetes].
    Cyganek K.
    Przegl Lek; 1999 Dec 20; 56(5):362-71. PubMed ID: 10554574
    [Abstract] [Full Text] [Related]

  • 31. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Dec 20; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 32. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS, Rose PA, Kim HM, Kehrer C, Brook RD.
    J Womens Health (Larchmt); 2007 Sep 20; 16(7):963-70. PubMed ID: 17903073
    [Abstract] [Full Text] [Related]

  • 33. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE, Qvigstad E.
    Adv Ther; 2008 Jun 20; 25(6):525-51. PubMed ID: 18568306
    [Abstract] [Full Text] [Related]

  • 34. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
    Godsland IF, Manassiev NA, Felton CV, Proudler AJ, Crook D, Whitehead MI, Stevenson JC.
    Clin Endocrinol (Oxf); 2004 May 20; 60(5):541-9. PubMed ID: 15104556
    [Abstract] [Full Text] [Related]

  • 35. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 20; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 20; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 37. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F.
    Acta Obstet Gynecol Scand; 2005 May 20; 84(5):474-7. PubMed ID: 15842212
    [Abstract] [Full Text] [Related]

  • 38. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey.
    Lowe GD, Upton MN, Rumley A, McConnachie A, O'Reilly DS, Watt GC.
    Thromb Haemost; 2001 Aug 20; 86(2):550-6. PubMed ID: 11522002
    [Abstract] [Full Text] [Related]

  • 39. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 40. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP.
    Pacing Clin Electrophysiol; 2005 Jan 20; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.